Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / *W EXP 05/24/202
-
Total 13F shares
-
59,856
-
Share change
-
+11,465
-
Total reported value
-
$110,000
-
Price per share
-
$1.84
-
Number of holders
-
3
-
Value change
-
+$20,999
-
Number of buys
-
2
-
Number of sells
-
1
Institutional Holders of NRX Pharmaceuticals, Inc. - *W EXP 05/24/202 (NRXPW) as of Q4 2021
As of 31 Dec 2021,
NRX Pharmaceuticals, Inc. - *W EXP 05/24/202 (NRXPW) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,856 shares.
The largest 3 holders included
Cambridge Investment Research Advisors, Inc., Yakira Capital Management, Inc., and UBS Group AG.
This page lists
3
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.